CLOV Sale Disclosure
Reynoso Jamie L. · SEC Form 4 · Filed Oct 20, 2026
Sale
Calculated transaction value
$17.93K
Reynoso Jamie L. CEO, Medicare Advantage
CLOV
Transaction date
Oct 19, 2026
Public filing date
Oct 20, 2026
Filing lag
Filed 1 day later
CLOV daily price context
Close on/before transaction
$4.44
Oct 19, 2026
First close after public filing
$4.78
Oct 21, 2026
Return after filing · so far
+3.14%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 4,066 shares @ $4.41
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001839066-26-000057
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$17.93K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Clover Health Investments, Corp. /de CLOV Current | Sale | Oct 19, 2026 | $17.93K |